Djamila Harouaka

FDA investigator · also recorded as Of Tris Djamila Harouaka

Appears on 15 documents from 2015 to 2023, most often at sites in California. Most often cites design and construction features (21 CFR 211.42).

15
Documents on file
5.5
Observations per 483
2015
First seen
2023
Most recent

What they cite most

From 76 observations

Activity by year

2015: 1, 2016: 5, 2017: 3, 2018: 2, 2020: 2, 2023: 2

Where

California 3 · China 3 · Maryland 3 · Virginia 2 · Connecticut 1 · Florida 1

Is Djamila Harouaka coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

15 documents, newest first
FirmOpen
483 Chongqing Biocare Pharmaceutical Ltd.Sep 22, 2023 · Chongqing, China
483 Chengdu Shengnuo Biopharm Co., Ltd.Sep 8, 2023 · Chengdu, China
483 Premier Pharmacy Labs Inc.Apr 29, 2020 · Weeki Wachee, Florida
483 Professional Arts PharmacyFeb 12, 2020 · Baltimore, Maryland
483 Intact Pharmaceuticals LLCOct 12, 2018 · New Milford, Connecticut
483 Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. (FDF Site)Apr 3, 2018 · Nanjing, China
483 Venator Germany GmbHSep 22, 2017 · Duisburg, Germany

About this profile

What does Djamila Harouaka inspect?

Djamila Harouaka appears on 15 documents on file covering 14 sites, most often in California.

What do they cite most often?

21 CFR 211.42 (design and construction features), followed by 21 CFR 211.113 and 21 CFR 211.22.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Djamila Harouaka is dated Sep 22, 2023.